Who Are We?
The mission of the Regenerative Medicine Foundation is to accelerate the discovery and development of new therapies for disease and translate those therapies into treatments for patients through the science of regenerative medicine.
Our vision is to accelerate the promise of regenerative medicine by exploring the body’s natural ability to heal itself.
The Regenerative Medicine Foundation is a 501(c)(3) not-for-profit foundation.
Our tax ID is 20-2710571.
Regenerative Medicine Foundation Conference 2013
The Regenerative Medicine Foundation Conference is designed to be the premier international event for leaders in regenerative medicine translation, representing academic and clinical research, health care policy, regulatory, reimbursement, venture investment and biotechnology industry interests. Held annually, the Conference seeks to advance the field of regenerative medicine and healthcare innovation through the sharing of scientific discoveries, best practices and business models.
The Young Minds in Regenerative Medicine Program is a commitment by the Regenerative Medicine Foundation to recognize and support promising young clinicians within 2 years of completing their training and those looking to extend their training specifically in the area of regenerative medicine. Awards will be made to promising clinicians who are conducting regenerative medicine research. Awards will also be issued to recognize students focused on the business development of the regenerative medicine industry.
Education and Awareness
The Regenerative Medicine Foundation believes it is essential to provide education and generate awareness about the science of regenerative medicine to the public. Through initiatives designed to reach out to all of the stakeholders in regenerative medicine, the Foundation has created programs to support the education of the military, patients, and the general public, as well as the venture capitalist, business, and scientific communities.
The Regenerative Medicine Foundation Corporate Council is an annual membership offered exclusively to the industry leaders who are committed to supporting the important work of the Regenerative Medicine Foundation. In return for their support, Council members receive unique opportunities to interact with industry stakeholders.
The Regenerative Medicine Foundation is an internationally-focused, not-for-profit organization created to enable the advancement of new treatments and therapies based on regenerative medicine, and ultimately, to realize the goals of personalized medicine.
Launched in 2005, the Foundation hosted one of the first regulatory meetings with the U.S. Food and Drug Administration (FDA) on the topic of regenerative medicine, and was instrumental in the formation of STRaC, the Soldier Treatment and Regeneration Consortium, a precursor to the Armed Forces Institute of Regenerative Medicine (AFIRM), and the Washington, DC-based Alliance for Regenerative Medicine.
Since its inception, the Foundation has hosted its inaugural 2010 Translational Regenerative Forum for the Regenerative Medicine Foundation. With over 400 people representing 19 different countries, convening in Winston-Salem, North Carolina, the Foundation had a successful inaugural meeting. With an impressive breadth of speakers, attendees were able to hear from 10 different panels, which discussed various topics relevant to the field of regenerative medicine, ranging from best practices to what is up next for the science.
In April, 2011, the 2nd Annual Forum was held in Washington, DC, then in Charlotte, NC, in 2012. These meetings featured keynote speakers and panelists from a US and international perspective including critical areas such as clinical trial design and obtaining regulatory approval. Regenerative medicine leaders from the academic, clinical, non-profit, and government and regulatory fields from around the world were in attendance. Through our extensive panels, the Forum featured the most up-to-date scientific breakthroughs, best practices in regenerative medicine, and the up-and-coming clinical trials.
This year's program will be held in San Francisco, California in mid-September.
The Regenerative Medicine Foundation has also formed its Young Minds initiative, a program that works to develop and support the career growth of students in regenerative medicine.
Through educational programs, translational conferences and public policy initiatives, the Foundation advocates for increased medical research, promotes the training and education of scientists, and facilitates the translation of therapies to patients.